Delivery Order SPE2DE24D0021-SPE2D625F3MCU
- Not listed
- Fisher Scientific Company L.L.C. was awarded a $3,099.96 fixed-price delivery order with economic price adjustment on August 11, 2025, to supply PROFILE-V 12 Panel DOA (Drugs of Abuse) Test kits at 25 per package. The contract, which is a child order under a larger vehicle, will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of August 25, 2025. No set-aside designation was used in this award. The funding source is identified as the Medical Supply Chain within the...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $1,277.88 for PROFILE-V 11 Panel DOA (Drugs of Abuse) Test kits, 25 per pack, with an ultimate completion date of September 5, 2025. This fixed-price contract with economic price adjustment was awarded on August 28, 2025, without a set-aside designation, indicating open competition. The award supports the Medical Supply Chain within the Department of Defense and will be performed in Pittsburgh, Pennsylvania. This...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,916.82 on September 19, 2025, for the procurement of Profile-V 11 Panel DOA (Drugs of Abuse) test kits, 25 per package. This is a fixed-price contract with economic price adjustment provisions and represents a child order under a larger contract vehicle. The contract carries no set-aside designation, indicating open competition. The place of performance is Pittsburgh, Pennsylvania, and the contract is scheduled for...
- Fisher Scientific Company L.L.C. has been awarded a delivery order contract valued at $8,266.56 for the procurement of PROFILE-V 12 Panel DOA (Drugs of Abuse) Test kits, 25 per pack, on July 24, 2025. The contract carries a fixed-price structure with economic price adjustment provisions and is scheduled for completion by July 31, 2025. This is an uncompensated delivery order with no set-aside designation, reflecting Fisher Scientific's competitive standing in open federal procurement. The...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $1,722.20 by the Defense Medical Supply Chain federal agency for the procurement of PROFILE-V 12 Panel DOA (Drugs of Abuse) Test kits, 25 per pack. This fixed-price delivery order with economic price adjustment was awarded on July 18, 2025, with an ultimate completion date of July 25, 2025, and will be performed in Pittsburgh, Pennsylvania. The award represents a child contract, indicating it falls under a larger...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $4,477.72 by the Medical Supply Chain, a defense-focused federal agency, for the procurement of Profile-V 12 Panel DOA (Drugs of Abuse) test kits (25 per package). This fixed-price delivery order with economic price adjustment authority was issued on September 5, 2025, with an ultimate completion date of September 12, 2025. The contract represents a child award under a larger vehicle structure and will be performed at...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $1,722.20 for the procurement of Profile-V 12-panel DOA (drugs of abuse) test kits, 25 per package. This fixed-price contract with economic price adjustment was awarded on May 27, 2025, with an ultimate completion date of June 3, 2025. The contract is being funded by the Medical Supply Chain, a defense-focused federal agency, with performance to be completed in Pittsburgh, Pennsylvania. This award represents a child...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,722.20 on August 22, 2025, for the supply of Profile-V 12-panel DOA (drugs of abuse) test kits, 25 per pack, under a fixed-price contract with economic price adjustment. The contract is set to be completed by August 29, 2025, and performance will take place in Pittsburgh, Pennsylvania. This award was issued by the Defense or Civilian Medical Supply Chain federal agency as part of a child contract with no set-aside...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,555.76 for the procurement of a PROFILE-V 11PNL DOA TEST 25/PK (a drug of abuse screening test product) on September 3, 2025. This fixed-price delivery order with economic price adjustment has an ultimate completion date of September 10, 2025 and will be performed in Pittsburgh, Pennsylvania. The contract was awarded without a set-aside designation, indicating open competition. The funding source is the Medical Supply...
- Fisher Scientific Company L.L.C. was awarded a $3,444.40 delivery order contract by the Department of Defense's Medical Supply Chain on July 22, 2025, for the procurement of an analytical profile kit for MedToxScan human urine testing. The contract, which is classified as a child award with no set-aside designation, is structured as a fixed-price delivery order with economic price adjustment provisions and will be performed in Pittsburgh, Pennsylvania. This award represents a continuation of...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F3MCUDelivery Order
Fisher Scientific Company L.L.C. was awarded a delivery order valued at $6,199.92 on September 15, 2025, for the procurement of PROFILE-V 12 panel DOA (drugs of abuse) test kits, 25 per package. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of September 29, 2025, and will be performed in Pittsburgh, Pennsylvania. The award was issued by the Medical Supply Chain within the Defense enterprise and represents an open competition procurement with no set-aside designation. Fisher Scientific, a major supplier of laboratory supplies, scientific instruments, and medical equipment to federal government agencies, continues to demonstrate its established capabilities as a critical vendor supporting government testing and research initiatives. This delivery order appears to be associated with Fisher Scientific's existing contract vehicles supporting the Department of Defense and related defense agencies' laboratory and testing operations. The company's extensive track record supplying specialized testing solutions, reagents, and laboratory supplies—including toxicology and drug screening products through its established Blanket Purchase Agreement with the Department of Veterans Affairs—positions it as a qualified provider for this drugs of abuse testing requirement. The relatively short completion window and specific product specification indicate this represents an urgent or immediate operational need within the federal defense supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 9/15/25 |